Abnormal Changes of Brain Cortical Anatomy and the Association with Plasma MicroRNA107 Level in Amnestic Mild Cognitive Impairment
- PMID: 27242521
- PMCID: PMC4870937
- DOI: 10.3389/fnagi.2016.00112
Abnormal Changes of Brain Cortical Anatomy and the Association with Plasma MicroRNA107 Level in Amnestic Mild Cognitive Impairment
Abstract
MicroRNA107 (Mir107) has been thought to relate to the brain structure phenotype of Alzheimer's disease. In this study, we evaluated the cortical anatomy in amnestic mild cognitive impairment (aMCI) and the relation between cortical anatomy and plasma levels of Mir107 and beta-site amyloid precursor protein (APP) cleaving enzyme 1 (BACE1). Twenty aMCI (20 aMCI) and 24 cognitively normal control (NC) subjects were recruited, and T1-weighted MR images were acquired. Cortical anatomical measurements, including cortical thickness (CT), surface area (SA), and local gyrification index (LGI), were assessed. Quantitative RT-PCR was used to examine plasma expression of Mir107, BACE1 mRNA. Thinner cortex was found in aMCI in areas associated with episodic memory and language, but with thicker cortex in other areas. SA decreased in aMCI in the areas associated with working memory and emotion. LGI showed a significant reduction in aMCI in the areas involved in language function. Changes in Mir107 and BACE1 messenger RNA plasma expression were correlated with changes in CT and SA. We found alterations in key left brain regions associated with memory, language, and emotion in aMCI that were significantly correlated with plasma expression of Mir107 and BACE1 mRNA. This combination study of brain anatomical alterations and gene information may shed lights on our understanding of the pathology of AD.
Clinical trial registration: http://www.ClinicalTrials.gov, identifier NCT01819545.
Keywords: Alzheimer’s disease; amnestic mild cognitive impairment; biological markers; genetics; surface-based morphometry.
Figures




Similar articles
-
Correlation Between Brain Structure Atrophy and Plasma Amyloid-β and Phosphorylated Tau in Patients With Alzheimer's Disease and Amnestic Mild Cognitive Impairment Explored by Surface-Based Morphometry.Front Aging Neurosci. 2022 Apr 25;14:816043. doi: 10.3389/fnagi.2022.816043. eCollection 2022. Front Aging Neurosci. 2022. PMID: 35547625 Free PMC article.
-
The feasibility of utilizing plasma MiRNA107 and BACE1 messenger RNA gene expression for clinical diagnosis of amnestic mild cognitive impairment.J Clin Psychiatry. 2015 Feb;76(2):135-41. doi: 10.4088/JCP.13m08812. J Clin Psychiatry. 2015. PMID: 25742200
-
Study of brain morphology change in Alzheimer's disease and amnestic mild cognitive impairment compared with normal controls.Gen Psychiatr. 2019 Apr 16;32(2):e100005. doi: 10.1136/gpsych-2018-100005. eCollection 2019. Gen Psychiatr. 2019. PMID: 31179429 Free PMC article.
-
Structural Alteration of Medial Temporal Lobe Subfield in the Amnestic Mild Cognitive Impairment Stage of Alzheimer's Disease.Neural Plast. 2022 Jan 24;2022:8461235. doi: 10.1155/2022/8461235. eCollection 2022. Neural Plast. 2022. PMID: 35111220 Free PMC article.
-
Longitudinal changes in surface based brain morphometry measures in amnestic mild cognitive impairment and Alzheimer's Disease.Neuroimage Clin. 2023;38:103371. doi: 10.1016/j.nicl.2023.103371. Epub 2023 Mar 8. Neuroimage Clin. 2023. PMID: 36924681 Free PMC article.
Cited by
-
Hepatic Amyloid Beta-42-Metabolizing Proteins in Liver Steatosis and Metabolic Dysfunction-Associated Steatohepatitis.Int J Mol Sci. 2024 Aug 12;25(16):8768. doi: 10.3390/ijms25168768. Int J Mol Sci. 2024. PMID: 39201455 Free PMC article.
-
Complexity analysis of cortical surface detects changes in future Alzheimer's disease converters.Hum Brain Mapp. 2017 Dec;38(12):5905-5918. doi: 10.1002/hbm.23773. Epub 2017 Aug 30. Hum Brain Mapp. 2017. PMID: 28856799 Free PMC article.
-
Abnormal changes in neuropsychological function, brain structure and cerebral perfusion in patients with unruptured intracranial aneurysms.Front Neurol. 2024 Oct 8;15:1463156. doi: 10.3389/fneur.2024.1463156. eCollection 2024. Front Neurol. 2024. PMID: 39440250 Free PMC article.
-
Systematic Review: microRNAs as Potential Biomarkers in Mild Cognitive Impairment Diagnosis.Front Aging Neurosci. 2022 Jan 12;13:807764. doi: 10.3389/fnagi.2021.807764. eCollection 2021. Front Aging Neurosci. 2022. PMID: 35095478 Free PMC article.
-
siRNA drug delivery across the blood-brain barrier in Alzheimer's disease.Adv Drug Deliv Rev. 2023 Aug;199:114968. doi: 10.1016/j.addr.2023.114968. Epub 2023 Jun 21. Adv Drug Deliv Rev. 2023. PMID: 37353152 Free PMC article. Review.
References
-
- Albert M. S., DeKosky S. T., Dickson D., Dubois B., Feldman H. H., Fox N. C., et al. . (2011). The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 7, 270–279. 10.1016/j.jalz.2011.03.008 - DOI - PMC - PubMed
-
- Casanova M. F., El-Baz A., Vanbogaert E., Narahari P., Switala A. (2010). A topographic study of minicolumnar core width by lamina comparison between autistic subjects and controls: possible minicolumnar disruption due to an anatomical element in-common to multiple laminae. Brain Pathol. 20, 451–458. 10.1111/j.1750-3639.2009.00319.x - DOI - PMC - PubMed
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical